nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—type 2 diabetes mellitus	0.353	1	CbGaD
Desvenlafaxine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0566	0.152	CbGbCtD
Desvenlafaxine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0504	0.136	CbGbCtD
Desvenlafaxine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0461	0.124	CbGbCtD
Desvenlafaxine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0403	0.109	CbGbCtD
Desvenlafaxine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0365	0.0982	CbGbCtD
Desvenlafaxine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0276	0.0744	CbGbCtD
Desvenlafaxine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0265	0.0713	CbGbCtD
Desvenlafaxine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0265	0.0713	CbGbCtD
Desvenlafaxine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.025	0.0675	CbGbCtD
Desvenlafaxine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0187	0.0503	CbGbCtD
Desvenlafaxine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0171	0.046	CbGbCtD
Desvenlafaxine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.000668	0.461	CbGeAlD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AGRP—type 2 diabetes mellitus	0.000511	0.0142	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PROX1—type 2 diabetes mellitus	0.000511	0.0142	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.000504	0.014	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—type 2 diabetes mellitus	0.000468	0.013	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—type 2 diabetes mellitus	0.000453	0.0126	CbGpPWpGaD
Desvenlafaxine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.000449	0.31	CbGeAlD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.000441	0.0123	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000434	0.0121	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000414	0.0115	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AANAT—type 2 diabetes mellitus	0.000409	0.0114	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PTGDS—type 2 diabetes mellitus	0.000409	0.0114	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000404	0.0112	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000404	0.0112	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.0004	0.0111	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000398	0.0111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Liver X Receptor Pathway—SREBF1—type 2 diabetes mellitus	0.000389	0.0108	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—AGT—type 2 diabetes mellitus	0.000383	0.0107	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.000379	0.0106	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MTNR1A—type 2 diabetes mellitus	0.00037	0.0103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000359	0.01	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000358	0.00997	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000347	0.00968	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000343	0.00954	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000334	0.0093	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PAX4—type 2 diabetes mellitus	0.000329	0.00918	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—AGT—type 2 diabetes mellitus	0.000329	0.00917	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.00031	0.00864	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000287	0.008	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—STAR—type 2 diabetes mellitus	0.00028	0.0078	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000272	0.00758	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000263	0.00732	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000258	0.00718	CbGpPWpGaD
Desvenlafaxine—SLC6A2—nerve—type 2 diabetes mellitus	0.000253	0.174	CbGeAlD
Desvenlafaxine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000248	0.00104	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000248	0.00104	CcSEcCtD
Desvenlafaxine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000248	0.00104	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000247	0.00104	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000247	0.00104	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000246	0.00104	CcSEcCtD
Desvenlafaxine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000246	0.00103	CcSEcCtD
Desvenlafaxine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000246	0.00103	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000245	0.00103	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000245	0.00103	CcSEcCtD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000244	0.00681	CbGpPWpGaD
Desvenlafaxine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000244	0.00103	CcSEcCtD
Desvenlafaxine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000244	0.00102	CcSEcCtD
Desvenlafaxine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000243	0.00102	CcSEcCtD
Desvenlafaxine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000242	0.00102	CcSEcCtD
Desvenlafaxine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000242	0.00102	CcSEcCtD
Desvenlafaxine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000242	0.00102	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000242	0.00102	CcSEcCtD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000242	0.00673	CbGpPWpGaD
Desvenlafaxine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000242	0.00102	CcSEcCtD
Desvenlafaxine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00102	CcSEcCtD
Desvenlafaxine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000241	0.00101	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00024	0.00101	CcSEcCtD
Desvenlafaxine—Tremor—Metformin—type 2 diabetes mellitus	0.00024	0.00101	CcSEcCtD
Desvenlafaxine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000239	0.00101	CcSEcCtD
Desvenlafaxine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000239	0.001	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000239	0.00665	CbGpPWpGaD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000238	0.001	CcSEcCtD
Desvenlafaxine—Tension—Irbesartan—type 2 diabetes mellitus	0.000237	0.000998	CcSEcCtD
Desvenlafaxine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000237	0.000997	CcSEcCtD
Desvenlafaxine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000237	0.000997	CcSEcCtD
Desvenlafaxine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000237	0.000996	CcSEcCtD
Desvenlafaxine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000236	0.000992	CcSEcCtD
Desvenlafaxine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000236	0.00099	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000235	0.000989	CcSEcCtD
Desvenlafaxine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000235	0.000988	CcSEcCtD
Desvenlafaxine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000234	0.000985	CcSEcCtD
Desvenlafaxine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000232	0.000974	CcSEcCtD
Desvenlafaxine—Alopecia—Losartan—type 2 diabetes mellitus	0.000231	0.000971	CcSEcCtD
Desvenlafaxine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000231	0.000971	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000231	0.00642	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00023	0.000968	CcSEcCtD
Desvenlafaxine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00023	0.000967	CcSEcCtD
Desvenlafaxine—Syncope—Metformin—type 2 diabetes mellitus	0.00023	0.000966	CcSEcCtD
Desvenlafaxine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000229	0.000964	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—HNF1B—type 2 diabetes mellitus	0.000228	0.00636	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000228	0.00635	CbGpPWpGaD
Desvenlafaxine—Rash—Glipizide—type 2 diabetes mellitus	0.000228	0.000959	CcSEcCtD
Desvenlafaxine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000228	0.000958	CcSEcCtD
Desvenlafaxine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000228	0.000958	CcSEcCtD
Desvenlafaxine—Headache—Glipizide—type 2 diabetes mellitus	0.000227	0.000953	CcSEcCtD
Desvenlafaxine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000227	0.000953	CcSEcCtD
Desvenlafaxine—Palpitations—Metformin—type 2 diabetes mellitus	0.000227	0.000952	CcSEcCtD
Desvenlafaxine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000226	0.000951	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000226	0.0063	CbGpPWpGaD
Desvenlafaxine—Shock—Valsartan—type 2 diabetes mellitus	0.000226	0.00095	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000225	0.000947	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000225	0.000947	CcSEcCtD
Desvenlafaxine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000225	0.000944	CcSEcCtD
Desvenlafaxine—Tension—Losartan—type 2 diabetes mellitus	0.000223	0.000939	CcSEcCtD
Desvenlafaxine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000223	0.000939	CcSEcCtD
Desvenlafaxine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000223	0.000938	CcSEcCtD
Desvenlafaxine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000223	0.000937	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000223	0.000936	CcSEcCtD
Desvenlafaxine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000223	0.000936	CcSEcCtD
Desvenlafaxine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000222	0.000934	CcSEcCtD
Desvenlafaxine—Hypertension—Metformin—type 2 diabetes mellitus	0.000221	0.00093	CcSEcCtD
Desvenlafaxine—Nervousness—Losartan—type 2 diabetes mellitus	0.000221	0.000929	CcSEcCtD
Desvenlafaxine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000221	0.000929	CcSEcCtD
Desvenlafaxine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00022	0.000927	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00022	0.000926	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.00022	0.00613	CbGpPWpGaD
Desvenlafaxine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000219	0.000922	CcSEcCtD
Desvenlafaxine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000219	0.000919	CcSEcCtD
Desvenlafaxine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000217	0.000914	CcSEcCtD
Desvenlafaxine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000217	0.000913	CcSEcCtD
Desvenlafaxine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000217	0.000912	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000217	0.000911	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000216	0.000907	CcSEcCtD
Desvenlafaxine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000216	0.000906	CcSEcCtD
Desvenlafaxine—Nausea—Glipizide—type 2 diabetes mellitus	0.000215	0.000903	CcSEcCtD
Desvenlafaxine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000215	0.000902	CcSEcCtD
Desvenlafaxine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000215	0.000902	CcSEcCtD
Desvenlafaxine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000214	0.0009	CcSEcCtD
Desvenlafaxine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000214	0.000899	CcSEcCtD
Desvenlafaxine—Tremor—Losartan—type 2 diabetes mellitus	0.000213	0.000897	CcSEcCtD
Desvenlafaxine—Rash—Glimepiride—type 2 diabetes mellitus	0.000213	0.000895	CcSEcCtD
Desvenlafaxine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000213	0.000894	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000213	0.000894	CcSEcCtD
Desvenlafaxine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000212	0.000892	CcSEcCtD
Desvenlafaxine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000212	0.000891	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000212	0.000891	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000212	0.0059	CbGpPWpGaD
Desvenlafaxine—Headache—Glimepiride—type 2 diabetes mellitus	0.000212	0.000889	CcSEcCtD
Desvenlafaxine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000211	0.000886	CcSEcCtD
Desvenlafaxine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000211	0.00587	CbGpPWpGaD
Desvenlafaxine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000209	0.000879	CcSEcCtD
Desvenlafaxine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000209	0.000878	CcSEcCtD
Desvenlafaxine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000208	0.000876	CcSEcCtD
Desvenlafaxine—Angioedema—Losartan—type 2 diabetes mellitus	0.000208	0.000874	CcSEcCtD
Desvenlafaxine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000208	0.000873	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000207	0.00575	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000207	0.00575	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000206	0.000867	CcSEcCtD
Desvenlafaxine—Shock—Metformin—type 2 diabetes mellitus	0.000206	0.000865	CcSEcCtD
Desvenlafaxine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000205	0.000863	CcSEcCtD
Desvenlafaxine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000205	0.000863	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000205	0.000862	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000205	0.000862	CcSEcCtD
Desvenlafaxine—Vertigo—Losartan—type 2 diabetes mellitus	0.000205	0.00086	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000205	0.00086	CcSEcCtD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000204	0.00569	CbGpPWpGaD
Desvenlafaxine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000204	0.000859	CcSEcCtD
Desvenlafaxine—Syncope—Losartan—type 2 diabetes mellitus	0.000204	0.000858	CcSEcCtD
Desvenlafaxine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000204	0.000857	CcSEcCtD
Desvenlafaxine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000203	0.000854	CcSEcCtD
Desvenlafaxine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000203	0.000851	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000202	0.00085	CcSEcCtD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000202	0.00563	CbGpPWpGaD
Desvenlafaxine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000202	0.00085	CcSEcCtD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000202	0.00563	CbGpPWpGaD
Desvenlafaxine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000201	0.000847	CcSEcCtD
Desvenlafaxine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000201	0.000847	CcSEcCtD
Desvenlafaxine—Palpitations—Losartan—type 2 diabetes mellitus	0.000201	0.000846	CcSEcCtD
Desvenlafaxine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000201	0.000843	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.0002	0.000841	CcSEcCtD
Desvenlafaxine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.0002	0.00084	CcSEcCtD
Desvenlafaxine—Asthenia—Glyburide—type 2 diabetes mellitus	0.0002	0.00084	CcSEcCtD
Desvenlafaxine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.0002	0.000839	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000198	0.000834	CcSEcCtD
Desvenlafaxine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000198	0.000833	CcSEcCtD
Desvenlafaxine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000198	0.000833	CcSEcCtD
Desvenlafaxine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000197	0.00083	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000197	0.00548	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000197	0.00548	CbGpPWpGaD
Desvenlafaxine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000196	0.000826	CcSEcCtD
Desvenlafaxine—Constipation—Valsartan—type 2 diabetes mellitus	0.000196	0.000826	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000196	0.00546	CbGpPWpGaD
Desvenlafaxine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000196	0.000824	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PRKAA1—type 2 diabetes mellitus	0.000196	0.00546	CbGpPWpGaD
Desvenlafaxine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000196	0.000823	CcSEcCtD
Desvenlafaxine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000195	0.000821	CcSEcCtD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000194	0.00542	CbGpPWpGaD
Desvenlafaxine—Shock—Irbesartan—type 2 diabetes mellitus	0.000194	0.000816	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MTNR1B—type 2 diabetes mellitus	0.000194	0.00541	CbGpPWpGaD
Desvenlafaxine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000194	0.000814	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000194	0.000814	CcSEcCtD
Desvenlafaxine—Anxiety—Losartan—type 2 diabetes mellitus	0.000193	0.000812	CcSEcCtD
Desvenlafaxine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000193	0.00081	CcSEcCtD
Desvenlafaxine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000192	0.000807	CcSEcCtD
Desvenlafaxine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000192	0.000807	CcSEcCtD
Desvenlafaxine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.000806	CcSEcCtD
Desvenlafaxine—Tension—Ramipril—type 2 diabetes mellitus	0.000192	0.000805	CcSEcCtD
Desvenlafaxine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000191	0.000804	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000191	0.000802	CcSEcCtD
Desvenlafaxine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000191	0.000802	CcSEcCtD
Desvenlafaxine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000191	0.000801	CcSEcCtD
Desvenlafaxine—Nervousness—Ramipril—type 2 diabetes mellitus	0.00019	0.000797	CcSEcCtD
Desvenlafaxine—Dry mouth—Losartan—type 2 diabetes mellitus	0.00019	0.000797	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000188	0.00524	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000188	0.00079	CcSEcCtD
Desvenlafaxine—Somnolence—Metformin—type 2 diabetes mellitus	0.000186	0.000782	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000185	0.00516	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000184	0.000774	CcSEcCtD
Desvenlafaxine—Tremor—Ramipril—type 2 diabetes mellitus	0.000183	0.000769	CcSEcCtD
Desvenlafaxine—Shock—Losartan—type 2 diabetes mellitus	0.000183	0.000768	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000182	0.000766	CcSEcCtD
Desvenlafaxine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000182	0.000764	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000182	0.00506	CbGpPWpGaD
Desvenlafaxine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000181	0.000762	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000181	0.00504	CbGpPWpGaD
Desvenlafaxine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000181	0.000761	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000181	0.000759	CcSEcCtD
Desvenlafaxine—Fatigue—Metformin—type 2 diabetes mellitus	0.00018	0.000758	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00018	0.000755	CcSEcCtD
Desvenlafaxine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000179	0.000754	CcSEcCtD
Desvenlafaxine—Constipation—Metformin—type 2 diabetes mellitus	0.000179	0.000752	CcSEcCtD
Desvenlafaxine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000178	0.00075	CcSEcCtD
Desvenlafaxine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000177	0.000745	CcSEcCtD
Desvenlafaxine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000177	0.000744	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000177	0.00492	CbGpPWpGaD
Desvenlafaxine—Rash—Glyburide—type 2 diabetes mellitus	0.000176	0.000738	CcSEcCtD
Desvenlafaxine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000176	0.000738	CcSEcCtD
Desvenlafaxine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000175	0.000737	CcSEcCtD
Desvenlafaxine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000175	0.000737	CcSEcCtD
Desvenlafaxine—Syncope—Ramipril—type 2 diabetes mellitus	0.000175	0.000736	CcSEcCtD
Desvenlafaxine—Headache—Glyburide—type 2 diabetes mellitus	0.000174	0.000733	CcSEcCtD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000174	0.00485	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—type 2 diabetes mellitus	0.000174	0.00483	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CPT1A—type 2 diabetes mellitus	0.000173	0.00482	CbGpPWpGaD
Desvenlafaxine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000172	0.000725	CcSEcCtD
Desvenlafaxine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000172	0.000721	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000172	0.000721	CcSEcCtD
Desvenlafaxine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000171	0.000719	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00017	0.000716	CcSEcCtD
Desvenlafaxine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00017	0.000716	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NAMPT—type 2 diabetes mellitus	0.00017	0.00473	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000169	0.00472	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000169	0.000711	CcSEcCtD
Desvenlafaxine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000169	0.000711	CcSEcCtD
Desvenlafaxine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000169	0.00071	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000169	0.0047	CbGpPWpGaD
Desvenlafaxine—Insomnia—Losartan—type 2 diabetes mellitus	0.000168	0.000706	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000167	0.000703	CcSEcCtD
Desvenlafaxine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000167	0.000701	CcSEcCtD
Desvenlafaxine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000166	0.000696	CcSEcCtD
Desvenlafaxine—Nausea—Glyburide—type 2 diabetes mellitus	0.000165	0.000695	CcSEcCtD
Desvenlafaxine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000165	0.000695	CcSEcCtD
Desvenlafaxine—Somnolence—Losartan—type 2 diabetes mellitus	0.000165	0.000694	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000165	0.000694	CcSEcCtD
Desvenlafaxine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000165	0.000693	CcSEcCtD
Desvenlafaxine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000163	0.000685	CcSEcCtD
Desvenlafaxine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000163	0.000683	CcSEcCtD
Desvenlafaxine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000162	0.000679	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—F7—type 2 diabetes mellitus	0.000161	0.00448	CbGpPWpGaD
Desvenlafaxine—Fatigue—Losartan—type 2 diabetes mellitus	0.00016	0.000673	CcSEcCtD
Desvenlafaxine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000159	0.000668	CcSEcCtD
Desvenlafaxine—Constipation—Losartan—type 2 diabetes mellitus	0.000159	0.000668	CcSEcCtD
Desvenlafaxine—Rash—Gliclazide—type 2 diabetes mellitus	0.000158	0.000663	CcSEcCtD
Desvenlafaxine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000158	0.000662	CcSEcCtD
Desvenlafaxine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000157	0.000661	CcSEcCtD
Desvenlafaxine—Shock—Ramipril—type 2 diabetes mellitus	0.000157	0.000659	CcSEcCtD
Desvenlafaxine—Headache—Gliclazide—type 2 diabetes mellitus	0.000157	0.000658	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000156	0.000657	CcSEcCtD
Desvenlafaxine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000155	0.000654	CcSEcCtD
Desvenlafaxine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000155	0.000653	CcSEcCtD
Desvenlafaxine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000155	0.00065	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000154	0.000647	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000154	0.00428	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000152	0.00423	CbGpPWpGaD
Desvenlafaxine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000152	0.000639	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SREBF1—type 2 diabetes mellitus	0.000151	0.00421	CbGpPWpGaD
Desvenlafaxine—Dizziness—Orlistat—type 2 diabetes mellitus	0.00015	0.000631	CcSEcCtD
Desvenlafaxine—Asthenia—Metformin—type 2 diabetes mellitus	0.00015	0.000631	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—type 2 diabetes mellitus	0.000149	0.00416	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000149	0.00414	CbGpPWpGaD
Desvenlafaxine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000149	0.000624	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000148	0.00413	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000147	0.0041	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000147	0.00409	CbGpPWpGaD
Desvenlafaxine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000146	0.000614	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000146	0.00406	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000145	0.000611	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000145	0.00405	CbGpPWpGaD
Desvenlafaxine—Rash—Valsartan—type 2 diabetes mellitus	0.000145	0.000609	CcSEcCtD
Desvenlafaxine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000145	0.000608	CcSEcCtD
Desvenlafaxine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000144	0.000607	CcSEcCtD
Desvenlafaxine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000144	0.000606	CcSEcCtD
Desvenlafaxine—Headache—Valsartan—type 2 diabetes mellitus	0.000144	0.000605	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—GHRL—type 2 diabetes mellitus	0.000143	0.00399	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000143	0.000602	CcSEcCtD
Desvenlafaxine—Rash—Orlistat—type 2 diabetes mellitus	0.000143	0.000602	CcSEcCtD
Desvenlafaxine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000143	0.000601	CcSEcCtD
Desvenlafaxine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000143	0.000601	CcSEcCtD
Desvenlafaxine—Headache—Orlistat—type 2 diabetes mellitus	0.000142	0.000598	CcSEcCtD
Desvenlafaxine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000142	0.000595	CcSEcCtD
Desvenlafaxine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000142	0.000595	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ADIPOQ—type 2 diabetes mellitus	0.000139	0.00387	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000138	0.000582	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000138	0.00386	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000138	0.00386	CbGpPWpGaD
Desvenlafaxine—Dizziness—Metformin—type 2 diabetes mellitus	0.000138	0.000582	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000138	0.000578	CcSEcCtD
Desvenlafaxine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000137	0.000577	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000137	0.000575	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000137	0.0038	CbGpPWpGaD
Desvenlafaxine—Nausea—Valsartan—type 2 diabetes mellitus	0.000136	0.000574	CcSEcCtD
Desvenlafaxine—Constipation—Ramipril—type 2 diabetes mellitus	0.000136	0.000573	CcSEcCtD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000136	0.00378	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000135	0.00377	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000135	0.000568	CcSEcCtD
Desvenlafaxine—Nausea—Orlistat—type 2 diabetes mellitus	0.000135	0.000567	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000134	0.00372	CbGpPWpGaD
Desvenlafaxine—Asthenia—Losartan—type 2 diabetes mellitus	0.000133	0.00056	CcSEcCtD
Desvenlafaxine—Vomiting—Metformin—type 2 diabetes mellitus	0.000133	0.000559	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000132	0.00368	CbGpPWpGaD
Desvenlafaxine—Rash—Metformin—type 2 diabetes mellitus	0.000132	0.000554	CcSEcCtD
Desvenlafaxine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000132	0.000554	CcSEcCtD
Desvenlafaxine—Headache—Metformin—type 2 diabetes mellitus	0.000131	0.000551	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000131	0.00364	CbGpPWpGaD
Desvenlafaxine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000131	0.000549	CcSEcCtD
Desvenlafaxine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000127	0.000534	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000127	0.00353	CbGpPWpGaD
Desvenlafaxine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000126	0.000528	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000125	0.00348	CbGpPWpGaD
Desvenlafaxine—Rash—Irbesartan—type 2 diabetes mellitus	0.000124	0.000523	CcSEcCtD
Desvenlafaxine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000124	0.000523	CcSEcCtD
Desvenlafaxine—Nausea—Metformin—type 2 diabetes mellitus	0.000124	0.000522	CcSEcCtD
Desvenlafaxine—Headache—Irbesartan—type 2 diabetes mellitus	0.000124	0.00052	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000124	0.00344	CbGpPWpGaD
Desvenlafaxine—Dizziness—Losartan—type 2 diabetes mellitus	0.000123	0.000516	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000121	0.00338	CbGpPWpGaD
Desvenlafaxine—Venlafaxine—CYP3A4—type 2 diabetes mellitus	0.00012	1	CrCbGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000119	0.00331	CbGpPWpGaD
Desvenlafaxine—Vomiting—Losartan—type 2 diabetes mellitus	0.000118	0.000497	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000118	0.00329	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000117	0.000493	CcSEcCtD
Desvenlafaxine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000117	0.000493	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000117	0.00326	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000117	0.00326	CbGpPWpGaD
Desvenlafaxine—Rash—Losartan—type 2 diabetes mellitus	0.000117	0.000492	CcSEcCtD
Desvenlafaxine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000117	0.000492	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000116	0.00324	CbGpPWpGaD
Desvenlafaxine—Headache—Losartan—type 2 diabetes mellitus	0.000116	0.000489	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000115	0.00321	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000115	0.00319	CbGpPWpGaD
Desvenlafaxine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000114	0.00048	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARGC1A—type 2 diabetes mellitus	0.000113	0.00315	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000112	0.00313	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—AVP—type 2 diabetes mellitus	0.000112	0.00311	CbGpPWpGaD
Desvenlafaxine—Nausea—Losartan—type 2 diabetes mellitus	0.00011	0.000464	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SIRT1—type 2 diabetes mellitus	0.000109	0.00305	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000109	0.000458	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000108	0.00301	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000107	0.00298	CbGpPWpGaD
Desvenlafaxine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000105	0.000443	CcSEcCtD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000105	0.00292	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000104	0.00289	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000103	0.00286	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000102	0.00283	CbGpPWpGaD
Desvenlafaxine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000101	0.000426	CcSEcCtD
Desvenlafaxine—Rash—Ramipril—type 2 diabetes mellitus	0.0001	0.000422	CcSEcCtD
Desvenlafaxine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.0001	0.000422	CcSEcCtD
Desvenlafaxine—Headache—Ramipril—type 2 diabetes mellitus	9.98e-05	0.00042	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	9.58e-05	0.00267	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	9.55e-05	0.00266	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	9.55e-05	0.00266	CbGpPWpGaD
Desvenlafaxine—Nausea—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000398	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—FAS—type 2 diabetes mellitus	9.4e-05	0.00262	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.2e-05	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.2e-05	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	9.18e-05	0.00256	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	9.09e-05	0.00253	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.03e-05	0.00252	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	9.02e-05	0.00251	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	8.79e-05	0.00245	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—LEP—type 2 diabetes mellitus	8.63e-05	0.0024	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	8.49e-05	0.00236	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	8.43e-05	0.00235	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	8.4e-05	0.00234	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	8.38e-05	0.00233	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.35e-05	0.00233	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	8.34e-05	0.00232	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	8.29e-05	0.00231	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	8.04e-05	0.00224	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	7.82e-05	0.00218	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	7.81e-05	0.00217	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.55e-05	0.0021	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	7.51e-05	0.00209	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.26e-05	0.00202	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.24e-05	0.00202	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	6.88e-05	0.00192	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	6.81e-05	0.0019	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	6.77e-05	0.00189	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	6.72e-05	0.00187	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	6.28e-05	0.00175	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.28e-05	0.00175	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6e-05	0.00167	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6e-05	0.00167	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.85e-05	0.00163	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.82e-05	0.00162	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.79e-05	0.00161	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	5.7e-05	0.00159	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—type 2 diabetes mellitus	5.52e-05	0.00154	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.1e-05	0.00142	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	4.89e-05	0.00136	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.87e-05	0.00136	CbGpPWpGaD
Desvenlafaxine—CYP3A4—kidney—type 2 diabetes mellitus	4.82e-05	0.0333	CbGeAlD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	4.75e-05	0.00132	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.73e-05	0.00132	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.66e-05	0.0013	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.57e-05	0.00127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.43e-05	0.00123	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.37e-05	0.00122	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.02e-05	0.00112	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4e-05	0.00111	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.97e-05	0.0011	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	3.94e-05	0.0011	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.83e-05	0.00107	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.66e-05	0.00102	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.62e-05	0.00101	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.61e-05	0.001	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.58e-05	0.000998	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.57e-05	0.000993	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.23e-05	0.000901	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—type 2 diabetes mellitus	3.22e-05	0.000897	CbGpPWpGaD
Desvenlafaxine—CYP3A4—liver—type 2 diabetes mellitus	3.04e-05	0.021	CbGeAlD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.03e-05	0.000845	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.77e-05	0.000772	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.73e-05	0.000761	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.4e-05	0.000669	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.11e-05	0.000589	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.85e-05	0.000514	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.85e-05	0.000514	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.75e-05	0.000488	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.75e-05	0.000488	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.67e-05	0.000465	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.54e-05	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.54e-05	0.000429	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.49e-05	0.000415	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.49e-05	0.000415	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.49e-05	0.000415	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.49e-05	0.000415	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.49e-05	0.000415	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.44e-05	0.000402	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.36e-05	0.000379	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.36e-05	0.000379	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.33e-05	0.00037	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.27e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.27e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.27e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.21e-05	0.000338	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.21e-05	0.000338	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.17e-05	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.17e-05	0.000325	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.15e-05	0.00032	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.13e-05	0.000314	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.13e-05	0.000314	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.13e-05	0.000314	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.06e-05	0.000295	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.93e-06	0.000277	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.59e-06	0.000267	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.59e-06	0.000267	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.59e-06	0.000267	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.59e-06	0.000267	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.2e-06	0.000256	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.55e-06	0.000238	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.98e-06	0.000222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.82e-06	0.000218	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.82e-06	0.000218	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.67e-06	0.000214	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.62e-06	0.000212	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.62e-06	0.000212	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.62e-06	0.000212	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.58e-06	0.000211	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.44e-06	0.000207	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.35e-06	0.000205	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.84e-06	0.00019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.84e-06	0.00019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.84e-06	0.00019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.71e-06	0.000187	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.65e-06	0.000185	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.51e-06	0.000181	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.25e-06	0.000174	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.18e-06	0.000172	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.18e-06	0.000172	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.93e-06	0.000165	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.93e-06	0.000165	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.11e-06	0.000142	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.11e-06	0.000142	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.09e-06	0.000142	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.02e-06	0.00014	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.87e-06	0.000136	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.74e-06	0.000132	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.65e-06	0.00013	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.55e-06	0.000127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.54e-06	0.000126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.42e-06	0.000123	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.36e-06	0.000122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.19e-06	0.000117	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.11e-06	0.000114	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.98e-06	0.000111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.91e-06	0.000109	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.9e-06	0.000109	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.85e-06	0.000107	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.4e-06	9.46e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.33e-06	9.28e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.05e-06	8.5e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.92e-06	8.13e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.92e-06	8.13e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.67e-06	7.44e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	3.74e-05	CbGpPWpGaD
